Aspartyl-alanyl-diketopiperazine

DB14940InvestigationalSmall molecule

Aspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).

Formula / weight: C₇H₁₀N₂O₄ · 186.167 g/mol (avg)

Resolves to

Compound

UNIIR9CHM391D5CAS110954-19-3

Structure

InChIKeyRVLCUCVJZVRNDC-IMJSIDKUSA-NSMILESC[C@@H]1NC(=O)[C@H](CC(O)=O)NC1=O

What you can answer from here — as of July 07, 2026

9Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which companies are running trials of Aspartyl-alanyl-diketopiperazine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account